Japanese Healthy Adult Male Participants Clinical Trial
Official title:
A Phase 1 Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects
The primary purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of a single dose of E6130 in Japanese healthy adult male participants.
This study consists of 8 cohorts, Cohorts 1 to 8. Cohorts 1 to 7 are designed as a single-center, single dose, placebo-controlled, randomized, ascending dose, double-blind study. Cohort 8 is designed as a single-center, single dose, randomized, open-label, two-group, two-period crossover study. Cohort 8 will be initiated after Cohorts 1 to 7 are completed. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03042299 -
A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation
|
Phase 1 | |
| Completed |
NCT03237156 -
Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants
|
Phase 1 |